Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: Evidence for a gender-related effect

Neuropsychobiology

Volumn 36, Issue 1, 1997, Pages 8-12

  Monteleone, Palmiero ^a   Catapano, Francesco ^a   Tortorella, Alfonso ^a   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cortisol; D Fenfiuramine; Obsessive compulsive disorder; Serotonin; Sex difference

Indexed keywords

DEXFENFLURAMINE; HYDROCORTISONE; PLACEBO; SEROTONIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEUROTRANSMISSION; OBSESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; FEMALE; FENFLURAMINE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES; SEROTONIN; SEX FACTORS;

EID: 0030957750     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119352     Document Type: Article

References (30)

1. Zohar J, Insel TR: Obsessive-compulsive disorder: Psychobiological approaches io diagnosis, treatment, and pathophysiology, Biol Psychiatry 1987:22:667-687.
2. Yatham LM, Steiner M: Neuroendocrine probes of serotonergic function: A critical review, LifeSci 1993;53:447-463.
3. Zohar J, Mueller EH, Insel TR, Zohar-Kadouch RC, Murphy DL: Serotonergic respon-sivity in obsessive-compulsive disorder: comparison of patients and healthy controls, Arch Gen Psychiatry 1987;44:946-951.
4. Zohar J, lnsel TR, Zohar-Cadouch RC, Hill JL, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorders, Arch Gen Psychiatry 1988;45:167-172.
5. Chamey DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR: Serotonin function in obsessive-compulsive disorder, A comparison of the effects of tryptophan and m-chlorophcnylpiperazine in patients and healthy subjects, Arch Gen Psychiatry 1988:45:177-185.
6. Bastani B, Nash F, Meltzer HY: Prolactin and cortisol responses to MK-212. a serotonin agonist, in obsessive-compulsive disorder, Arch Gen Psychiatry 1990:47:833-839.
7. Hollander E, DcCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Licbowitz MR: Serotonergic function in obsessive-compulsive disorder, Behavioral and neuroendocrine responses to oral m-chlorophc-nylpiperazine and fenfluramine in patients and healthy volunteers, Arch Gen Psychiatry 1992; 49:21-28.
8. Invemizzi R, Bcrettera G, Garattini S, Sama-nin R:D-and /,-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat, Eur J Pharmacol 1986;120:9-15.
9. Garattini S, Mennini T, Samanin R: From fenfluramine racemate to fenfluramine, Ann NY Acad Sci 1987:499:156-166.
10. Monteleone P, Catapano F, Bortolotli F, Maj M: Plasma prolactin response to fenfluramine in obsessive-compulsive patients before and after fluvoxaminc treatment, Biol Psychiatry, in press.
11. Goodman WK, Price LH, Rasmussen SA, Riddle MA, Pauls DL, Leckman JF: The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), 1: Development, use, and reliability, Arch Gen Psychiatry 1989:46:1006-1011.
12. Hamilton MA: A rating scale for depression, J Neurol Ncurosurg Psychiatry 1960:23:56-62.
13. Catapano F, Monteleone P, Fuschino A, Maj M, Kcmali D: Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder, Psychiatry Res 1992;44:217-225.
14. Monteleone P, Catapano F, Del Buono G, Maj M: Circadian rhythms of melatonin, cortisol and prolactin in patients wiffi obsessive-compulsive disorder, Acta Psychiatr Scand 1994: 89:411-415.
15. Monteleone P, Catapano F, Tortorella A, Di Martino S, Maj M: Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment, Psycho neurocndocrinology 1995;20:763-770.
16. Asbcrg M, Thorcn P, Bertilsson L: Clomipramine treatment of obsessive disorder: Biochemical and clinical aspects, Psychopharma-col Bull 1982;18:13-21.
17. Inscl TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL: The dexamethasone suppression test in patients w ith primary obsessive compulsive disorder, Psychiatry Res 1982;6: 160-163.
18. Cottreaux JA, Bouvard M, Claustrat B, Jucnet C: Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report, Psychiatry Res 1984.13: 157-165.
19. Catapano F, Monteleone P, Maj M, Kcmali D: Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls, Neuropsychobiology 1990:23:53-56.
20. Gehris TL: Urinary' free cortisol levels in obsessive-compulsive patients, Psychiatry' Res 1990: 32:151-158.
21. Goodwin GM, Murray CL, Bancroft J: Orald-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men, J Affect Disord 1994;30:117-122.
22. Bond AJ, Feizollah S, Lader MH: The effects of fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function, J Psychopharmacol 1995;9:1-8.
23. O’Keane V, McLoughlin D, Dinan TG: γ-Fenfluramine-induced prolactin and cortisol release in major depression: response to treatment, J Affect Disord 1992:26:143-150.
24. Lucey JV, O'Keanc V, Butcher G, Clare AW, Dinan TG: Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: A comparison with depressed and healthy controls, Br J Psychiatry 1992; 161:517-521.
25. Palazidou E, Stephenson J, Butler J, Coskeran P, Chambers S, McGregor AM: Evidence for 5-hydroxytryptamine-lA receptor involvement in the control of prolactin secretion in man, Psychopharmacology 1995:119:311-314.
26. Munaro NI: The effect of ovarian steroids on hypothalamic 5-hvdroxytryptamine neuronal activity, Neuroendocrinology 1978:26:270-276.
27. Fischette CT, Bigeon A, McEwen BS: Sex steroid modulation of the serotonin behavioral syndrome, LifeSci 1984;35:1997-2006.
28. von Knorring L, Oreland R, Haggendal J, Mag-nusson T, Almay B, Johansson F: Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients, J Neural Transnt 1986:66:37-46.
29. O’Keane V, O’Hanlon M, Webb M, Dinan T: Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration, Clin Endocrinol 1991;34: 289-292.
30. Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJG: Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects, Int Clin Psychopharmacol 1993;8:123-128.